Publicacions en col·laboració amb investigadors/es de Netherlands Cancer Institute (9)

2007

  1. Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones

    Drug Metabolism and Disposition, Vol. 35, Núm. 10, pp. 1873-1879

  2. Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk

    Molecular and Cellular Biology, Vol. 27, Núm. 4, pp. 1247-1253

2006

  1. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion

    Drug Metabolism and Disposition, Vol. 34, Núm. 4, pp. 690-695

  2. Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk

    Carcinogenesis, Vol. 27, Núm. 1, pp. 123-130

2005

  1. Human cancer resistance protein: Interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine

    Journal of Pharmacology and Experimental Therapeutics, Vol. 312, Núm. 1, pp. 144-152

  2. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver

    Molecular Pharmacology, Vol. 67, Núm. 5, pp. 1765-1771

  3. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin

    Molecular Pharmacology, Vol. 67, Núm. 5, pp. 1758-1764

  4. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk

    Nature Medicine, Vol. 11, Núm. 2, pp. 127-129

  5. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2)

    Drug Metabolism and Disposition, Vol. 33, Núm. 5, pp. 614-618